Does OCRELIZUMAB Cause Paralysis? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Paralysis have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.2% of all adverse event reports for OCRELIZUMAB.
125
Reports of Paralysis with OCRELIZUMAB
0.2%
of all OCRELIZUMAB reports
2
Deaths
66
Hospitalizations
How Dangerous Is Paralysis From OCRELIZUMAB?
Of the 125 reports, 2 (1.6%) resulted in death, 66 (52.8%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Paralysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Paralysis?
ADALIMUMAB (275)
INTERFERON BETA-1A (181)
METHOTREXATE (181)
PREGABALIN (171)
RITUXIMAB (166)
ATORVASTATIN (160)
DIMETHYL (156)
FINGOLIMOD (145)
NATALIZUMAB (136)
ETANERCEPT (134)
Which OCRELIZUMAB Alternatives Have Lower Paralysis Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE